Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Eiger BioPharmaceuticals"
Count: 22
Selected: 0
NCT02430181Lonafarnib With and Without Ritonavir in HDV (LOWR-1)
NCT05070364Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV
NCT02527707Titrating-Dose of Lonafarnib in Combination With Ritonavir
NCT03373435Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
NCT03719313Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
NCT03895528Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy
NCT00945880Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive
NCT02765802A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
NCT02968641A Study of Lonafarnib With or Without Ritonavir in Patients With HDV
NCT02700529Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA)
NCT02736149Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
NCT02664558A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
NCT02430194Lonafarnib With Ritonavir in HDV (LOWR-2)
NCT01316185Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
NCT04652479Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia
NCT04343976Pegylated Interferon Lambda Treatment for COVID-19
NCT04344600Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection
NCT05229991Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection
NCT04388709Interferon Lambda Therapy for COVID-19
NCT02771574Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia
NCT00916747Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
NCT04727424Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms